CN101816422A - Oenothera biennise oil fat emulsion oral solution, drink and preparation method thereof - Google Patents
Oenothera biennise oil fat emulsion oral solution, drink and preparation method thereof Download PDFInfo
- Publication number
- CN101816422A CN101816422A CN201010158455A CN201010158455A CN101816422A CN 101816422 A CN101816422 A CN 101816422A CN 201010158455 A CN201010158455 A CN 201010158455A CN 201010158455 A CN201010158455 A CN 201010158455A CN 101816422 A CN101816422 A CN 101816422A
- Authority
- CN
- China
- Prior art keywords
- oenothera
- biennise
- oil
- oral solution
- fat emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides oenothera biennise oil fat emulsion oral solution, a drink and a preparation method thereof. The oenothera biennise oil fat emulsion oral solution is prepared from refined oenothera biennise oil, intralipid, glycerol, sterilized pure water, an antioxidant, a stabilizer, a pH regulator, a flavoring agent, spice and the like serving as raw materials. The preparation process comprises the following steps of: dissolving the refined oenothera biennise oil and the intralipid by heating to form oil-phase liquid under the protection of nitrogen gas; mixing and dissolving the glycerol, the antioxidant, the stabilizer, the flavoring agent, the spice and the sterilized pure water to form water-phase liquid; slowly adding the oil-phase liquid into the violently stirred water-phase liquid; cutting the mixture at a high speed to form a primary emulsion; adjusting the pH of the primary emulsion within the range from 6.5 to 8.5 with a small amount of pH regulator; then emulsifying the primary emulsion with a high pressure homogenizer; filtering the primary emulsion with a micro-porous membrane filter; and encapsulating, sealing and performing microwave sterilization and heat sterilization so as to obtain the oenothera biennise oil fat emulsion oral solution which contains 1 to 50 percent of oenothera biennise oil. The oenothera biennise oil fat emulsion oral solution is used in the field of the health food; the high-concentration fat emulsion oral solution containing 5 to 50 percent of oenothera biennise oil can be used as a health-care drink with a nutritional function; and the low-concentration fat emulsion oral solution containing 1 to 20 percent of oenothera biennise oil can be used as a dinner table drink and a popular drink.
Description
Technical field
The invention belongs to the healthy food field, relate to a kind of oenothera biennise oil fat emulsion oral solution, beverage and manufacture method, this invention is by evening primrose oil, emulsifying agent, water after emulsification, reaches below 800 nanoscales oil droplet size, form chylomicron, oral back enters blood circulation, directly by body or cell institute digestibility and utilization in the easier absorption of intestines and stomach.
The fat emulsion oral solution of 5-50% high concentration is as trophism functional health drink, and the fat emulsion oral solution of 1-20% low concentration is as dining table beverage and popular drink.
This oenothera biennise oil fat emulsion oral solution, beverage are used for pregnant woman, infant, children, student, a middle-aged person, the elderly, provide with added body in essential fatty acid;
Oenothera biennise oil fat emulsion oral solution, the research and development of beverage and production for directly drinking evening primrose oil, provide and additional essential fatty acid, and a reliable and effective method and approach are provided.
Background technology
Evening primrose claims cordate telosma, screwtree root, white dead nettle again, is Oenotheraceae Oenothera evening primrose (Oenothera biennis), originates in the temperate zone, America, in state-owned introducing a fine variety.
Evening primrose oil is to produce from the seed of evening primrose maturation, and grass-seed oil content not of the same race is 15%～25%.Contain amounts of protein and fat in the evening primrose benevolence, its vegetalitas unsaturated fatty acid content 〉=80%, linoleic acid content 〉=73%, gamma-linolenic acid content 〉=9%, and the content ratio of polyunsaturated fatty acid is higher, linoleic acid content is the highest, thereby evening primrose oil has functional characteristic clearly.
Evening primrose oil and the contrast of other edible oil main components
In the table as can be seen in the evening primrose oil polyunsaturated fatty acid reach more than 80%, its main component is a linoleic acid 73.40%, wherein gamma-linolenic acid content is up to more than 9%.
Evening primrose oil is the most important nutrient drug of finding this century.Can treat multiple disease, regulate lipid material in the blood, diseases such as the coronary artery infraction that high cholesterol, high fat of blood are caused, atherosis and cerebral thrombus have significant curative effect and important medical value.
China pharmaceutical control and administration department approved evening primrose oil soft capsule and the moon are seen oil emu kind listing, are being widely used aspect treatment hypertension, prevention of brain thrombus, lipopenicillinase, hypoglycemic, anti-ageing the waiting for a long time and curative effect preferably.
Gamma-Linolenic acid Gamma linolenic Acid (octatecatrienoic acid, vitaminF, OctadecatrienoicAcid GLA) is present in the oil of human milk and some seed plant, cryptogam, as containing this product 7%～10% in its seed oil of willow leaf section evening primrose (Oenotherabiennis).Also contain this product in the oil of Boraginaceae borage (borage) and black gooseberry.The gamma-Linolenic acid of producing both at home and abroad is mainly derived from evening primrose at present.
This product is to form the structural material of each tissue biological's film of human body, also is the precursor of synthesis of prostaglandins.As unrighted acid essential in the human body, adult's daily requirement amount is about 36mg/kg.As the intake deficiency, can cause the disorder of function in the body, cause some disease, as diabetes, high fat of blood etc.
Pharmacology and application experiment and clinical research show, this product has tangible anti peroxidation of lipid, reduce T-CHOL, improve HDL, suppress platelet aggregation and thromboxane A2 synthesizes, brings high blood pressure down, suppresses effects such as ulcer and gastrorrhagia, increase insulin secretion, fat-reducing.Be used for some geriatric disease such as diabetes, high fat of blood, atherosclerotic, thrombus cardiovascular and cerebrovascular disease, cancer and gastric ulcer, obesity, schizophrenia, AE, rheumatic arthritis, vasculitis etc. clinically.
Gamma-Linolenic acid can change into PGE1 at human body, can suppress the formation of hematoblastic gathering and thromboxane A2, the effect that has tangible antithrombotic and anti-atherogenic patch to form, can significantly reduce high fat of blood, cholesterol and blood sugar, reduction density lipoproteins etc. delay senility and the women also has significant curative effect through preceding symptom.
Its content of gamma-Linolenic acid goods that extracts from natural plants at present is mostly at 4-11%.According to international pharmacology analysis expert, have only when gamma-linolenic acid content to reach 15% when above, just can play significant pharmacological treatment effect.
It is to be derived by linoleic acid that gamma-Linolenic acid and alpha-linolenic acid are different from gamma-Linolenic acid, is the polyunsaturated fatty acid that belongs to ω-6 series, and the further derivative of gamma-Linolenic acid is an arachidonic acid, and can not be derivatized to DHA, EPA.
Arachidonic acid: ARA (AA) formal name used at school eicosatetraenoic acid belongs to ω-6 clan elder chain polybasic unsaturated fatty acid.
The arachidonic acid that is transformed by linoleic acid is the important substance that human brain and optic nerve are grown, and has important function to improving intelligence and strengthening visual acuity.
Belong to essential fatty acid at child ARA in period, the shortage of ARA is for the growth of human tissue organ, and especially brain and nervous system development may the serious harmful effects of product.Growth descendant physical efficiency is transformed by essential fatty acids linoleic, leukotrienes, therefore belongs to half essential fatty acid.
Except, highly purified arachidonic acid is synthesis of prostaglandins (prostaglandins), the direct precursor of thromboxane element (thromboxanes) and leukotrienes 20 carbon derivatives such as (leukotrienes), these biological active matter confrontation cardiovascular system of human body and immune system have a very important role.
Arachidonic acid also has esterified cholesterol, increases blood vessel elasticity, reduces blood viscosity, regulates a series of physiologically actives such as haemocyte function.Arachidonic acid has important effect to angiocardiopathy preventing, diabetes and tumour etc.
Drink the evening primrose oil goods, replenish the needs of human body to gamma-Linolenic acid, increase arachidonic acid concentration in vivo, have improve immune function of human body, promote resistance against diseases, eliminate the body brainfag, effect such as delay senility, be applicable to worn with age, hyperlipemia, hypertension, atherosclerotic, diabetes etc.
Have only evening primrose oil crude oil products and evening primrose oil soft capsule on the domestic market at present, evening primrose oil is directly taken and is difficult for absorbing, or absorbs not exclusively, takes evening primrose oil especially in a large number or for a long time and can cause the diarrhoea side effect.
For this reason, this invention be evening primrose oil by emulsification after, particle diameter reaches below 800 nanoscales, forms chylomicron, oral back enters blood circulation, directly by body or cell institute digestibility and utilization in the easier absorption of intestines and stomach.
Oenothera biennise oil fat emulsion oral solution, the research and development of beverage and production for directly drinking evening primrose oil, replenish essential fatty acid, and a reliable and effective method and approach are provided.
Summary of the invention
The object of the invention provides a kind of oenothera biennise oil fat emulsion oral solution, beverage and manufacture method.
Evening primrose oil (Oenothera Biennise Oil) is the seed oenothera seed of Oenotheraceae Oenothera evening primrose (Oenothera biennis), presses through colding pressing or the refining oily liquids that forms of hot pressing press for extracting juice extraction.
Oenothera biennise oil fat emulsion oral solution, beverage formula are: every 1000ml fat breast contains refinement of evening primrose oil 1-50%, emulsion 1.0-15.0%, isotonic regulator 1.0-5.0%, antioxidant 0.01-0.5%, stabilizing agent 0.1-10%, it is 6.5-8.5 that flavor enhancement 0.01-10%, pH conditioning agent are transferred fat emulsion pH, and all the other are sterile pure water.
Oenothera biennise oil fat emulsion oral solution, drink and production process flow process are:
A) under nitrogen protection, refinement of evening primrose oil is heated to 60-90 ℃, stir the adding emulsifying agent and form oil phase liquid until dissolving;
B) with glycerine, antioxidant, stabilizing agent, flavor enhancement, join in the aseptic pyrogen-free sterile pure water, stirring and dissolving forms water liquid;
C) under nitrogen protection, in the intensively stirred water liquid of the slow adding of oil phase liquid, strong agitation forms colostric fluid;
D), regulate the pH to 6.5-8.5 of colostric fluid with a spot of pH conditioning agent;
E) use high pressure homogenizer under the pressure of 500-25000psi, with colostrum emulsifying repeatedly, the granularity of prepared fat breast is less than 2 microns, and its average particle size range is the 20-500 nanometer;
F) with the filtration sterilization of the process of the fats emulsion behind homogeneous 0.22-0.8 micron microporous membrane filters, under aseptic GMP clean environment, quantitatively pour in the packing container (the glass bottle, mould bottle, PVC bag, non-PVC bag, mould packaging paper product and metal can packing), seal behind the inflated with nitrogen;
G) but the fats emulsion goods of package encapsulation are placed microwave sterilization, also heat sterilization.
The specific embodiment
Below the present invention is described, but the present invention is limited in the example not exclusively by concrete case study on implementation.
Embodiment one,
Prescription: refinement of evening primrose oil 50g, edible lecithin 3g, edible glycerol 6g, stabilizing agent is an amount of, sweetener is an amount of, flavoring essence is an amount of, and the NaOH thin liquid is an amount of, and sterile pure water adds to 1000ml.
1, preparation oil phase liquid: get the edible refinement of evening primrose oil of formula ratio, edible lecithin, under nitrogen protection, be heated to 80 ℃ of stirrings and make that to be dissolved into oil phase liquid standby;
2, preparation water liquid: it is standby that edible glycerol, stabilizing agent, sweetener, flavoring essence and the sterile pure water of getting formula ratio is stirred into water liquid;
3, first emulsion: under nitrogen protection, under water liquid high-speed stirred, lentamente oil phase liquid is splashed into water liquid, after dripping off, use the high speed shear agitator, first emulsification 15 minutes;
4, regulate pH: under agitation, transfer pH7.4, and add sterile pure water to the full dose of filling a prescription with dilute sodium hydroxide water liquid;
5, emulsifying: utilize the high pressure homogenization machine with colostric fluid homogeneous repeatedly, adjusting pressure is 15000psi, and homogeneous 3-6 time is in the 100-400nm scope up to the newborn particle diameter of fat;
6, filter can: fats emulsion behind the filtering with microporous membrane in 0.8 μ m aperture, is poured into 600ml and moulds in the bottle, fill nitrogen, sealing;
7, sterilization: place the rotary steam Sterilization Kettle to sterilize the fats emulsion of filling and sealing, sterilized F0 value 15 minutes 30 minutes for 115 ℃.Promptly get finally 5% oenothera biennise oil fat emulsion oral beverage products.
Embodiment two,
Prescription: refinement of evening primrose oil 300g, edible lecithin 18g, edible glycerol 30g, stabilizing agent is an amount of, sweetener is an amount of, essence is an amount of, and the NaOH thin liquid is an amount of, and sterile pure water adds to 1000ml.
1, preparation oil phase liquid: get the edible refinement of evening primrose oil of formula ratio, edible lecithin, under nitrogen protection, be heated to 80 ℃ of stirrings and make that to be dissolved into oil phase liquid standby;
2, preparation water liquid: it is standby that edible glycerol, stabilizing agent and the sterile pure water of getting formula ratio is stirred into water liquid;
3, first emulsion: under nitrogen protection, under water liquid high-speed stirred, lentamente oil phase liquid is splashed into water liquid, after dripping off, use the high speed shear agitator, first emulsification 15 minutes;
4, regulate pH: under agitation, transfer pH7.4, add sweetener, flavoring essence, and add sterile pure water to the full dose of filling a prescription with dilute sodium hydroxide water liquid;
5, emulsifying: utilize the high pressure homogenization machine with colostric fluid homogeneous repeatedly, adjusting pressure is 15000psi, and homogeneous 3-6 time is in the 100-400nm scope up to the newborn particle diameter of fat;
6, filter can: fats emulsion behind the filtering with microporous membrane in 0.8 μ m aperture, is poured in the 10ml glass bottle, fill nitrogen, sealing;
7, sterilization: the fats emulsion of filling and sealing is placed the microwave bacteria degermer sterilization, promptly get finally 30% oenothera biennise oil fat emulsion oral solution, as trophism functional health drink.
Embodiment three,
Prescription: refinement of evening primrose oil 100g, edible lecithin 6g, edible glycerol 12g, stabilizing agent is an amount of, sweetener is an amount of, essence is an amount of, and the NaOH thin liquid is an amount of, and sterile pure water adds to 1000ml.
1, preparation oil phase liquid: get the edible refinement of evening primrose oil of formula ratio, edible lecithin, under nitrogen protection, be heated to 80 ℃ of stirrings and make that to be dissolved into oil phase liquid standby;
2, preparation water liquid: it is standby that edible glycerol, stabilizing agent, sweetener, flavoring essence and the sterile pure water of getting formula ratio is stirred into water liquid;
3, first emulsion: under nitrogen protection, under water liquid high-speed stirred, lentamente oil phase liquid is splashed into water liquid, after dripping off, use the high speed shear agitator, first emulsification 15 minutes;
4, regulate pH: under agitation, transfer pH7.4, and add sterile pure water to the full dose of filling a prescription with dilute sodium hydroxide water liquid;
5, emulsifying: utilize the high pressure homogenization machine with colostric fluid homogeneous repeatedly, adjusting pressure is 15000psi, and homogeneous 3-6 time is in the 100-400nm scope up to the newborn particle diameter of fat;
6, filter can: fats emulsion behind the filtering with microporous membrane in 0.8 μ m aperture, is poured in the 240ml metal can, fill nitrogen, sealing;
7, sterilization: place the rotary steam Sterilization Kettle to sterilize the fats emulsion of filling and sealing, sterilized F0 value 15 minutes 30 minutes for 115 ℃.Promptly get finally 10% oenothera biennise oil fat emulsion oral beverage products.
Claims (10)
1. oenothera biennise oil fat emulsion oral solution, beverage, it is characterized in that this prescription is: every 1000ml oenothera biennise oil fat emulsion oral solution contains refinement of evening primrose oil 1-50%, emulsifying agent 1.0-15.0%, isotonic regulator 1.0-5.0%, antioxidant 0.01-0.5%, stabilizing agent 0.1-10%, flavor enhancement 0.01-10%, pH conditioning agent are transferred fats emulsion pH to 6.5-8.5, and all the other are sterile pure water.
2. oenothera biennise oil fat emulsion oral solution according to claim 1, beverage, it is characterized in that described refinement of evening primrose oil (Oenothera Biennise Oil) is the seed of Oenotheraceae Oenothera plant evening primrose (Oenothera biennis), shell and press or the refining oily liquids that forms of hot pressing press for extracting juice extraction through colding pressing.
3. oenothera biennise oil fat emulsion oral solution according to claim 1, beverage is characterized in that described emulsifying agent is a kind of or several in refined lecithin, soybean lecithin, egg yolk lecithin, poloxamer, polyethylene glycol glycerol ester, the polyoxyethylene methyl castor oil ether.
4. oenothera biennise oil fat emulsion oral solution according to claim 1, beverage is characterized in that described isotonic regulator is a kind of or several in glycerine, sorbierite, the sweet dew alcohol and glucose.
5. oenothera biennise oil fat emulsion oral solution according to claim 1, beverage is characterized in that described antioxidant is one or more in vitamin E, vitamin C, sodium hydrogensulfite, the natrium adetate.
6. oenothera biennise oil fat emulsion oral solution according to claim 1, beverage is characterized in that described stabilizing agent is one or more in hydroxy propyl-Beta-cyclodextrine, polyethylene glycol, polyvinylpyrrolidone, hydroxypropyl methylcellulose, the oligomeric generation hydroxypropyl cellulose.
7. oenothera biennise oil fat emulsion oral solution according to claim 1, beverage, it is characterized in that described pH conditioning agent is one or more mixing materials in hydrochloric acid, NaOH, phosphoric acid, phosphate, citric acid, citrate, acetic acid, the acetate, regulate oenothera biennise oil fat emulsion oral solution pH scope at 6.5-8.5.
8. oenothera biennise oil fat emulsion oral solution according to claim 1, beverage, it is characterized in that described flavor enhancement is sodium chloride, wood sugar, lactose, fructose, sucrose, one or more in the flavor enhancements such as A Siba is sweet, Sucralose, honey element, flavoring orange essence, lemon extract, strawberry essence, lychee flavor, fragrant burnt odor essence, flavoring pineapple essence.
9. oenothera biennise oil fat emulsion oral solution according to claim 1, beverage is characterized in that described preparation technology is:
A) under nitrogen protection, refinement of evening primrose oil is heated to 60-90 ℃, stir the adding emulsifying agent and form oil phase liquid until dissolving;
B) glycerine, antioxidant, stabilizing agent, flavor enhancement are joined in the sterile pure water, stirring and dissolving forms water liquid;
C) under nitrogen protection, in the intensively stirred water liquid of the slow adding of oil phase liquid, strong agitation forms colostric fluid;
D), regulate the pH to 6.5-8.5 of colostric fluid with a spot of pH conditioning agent;
E) use high pressure homogenizer under the pressure of 500-25000psi, with colostrum emulsifying repeatedly, the granularity of prepared fats emulsion is less than 2 microns, and its average particle size range is the 20-500 nanometer;
F) with the filtration sterilization of the process of the fats emulsion behind homogeneous 0.22-0.8 micron microporous membrane filters, in aseptic GMP clean environment, quantitatively pour in the packing container (the glass bottle, mould bottle, PVC bag, non-PVC bag, mould packaging paper product and metal can packing), seal behind the inflated with nitrogen;
G) the fats emulsion goods with package encapsulation place microwave bacteria degermer sterilization, heat sterilization.
10. oenothera biennise oil fat emulsion oral solution according to claim 1, beverage, it is characterized in that being applied to the healthy food field, make the oenothera biennise oil fat emulsion oral solution of high concentration, containing evening primrose oil is 5-50%, packing specification is 5-100ml, as trophism functional health drink; The oenothera biennise oil fat emulsion oral solution of low concentration, containing evening primrose oil is 1-20%, packing specification is 30-5000ml, as dining table beverage and popular drink.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010158455A CN101816422A (en) | 2010-04-22 | 2010-04-22 | Oenothera biennise oil fat emulsion oral solution, drink and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010158455A CN101816422A (en) | 2010-04-22 | 2010-04-22 | Oenothera biennise oil fat emulsion oral solution, drink and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101816422A true CN101816422A (en) | 2010-09-01 |
Family
ID=42651825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010158455A Pending CN101816422A (en) | 2010-04-22 | 2010-04-22 | Oenothera biennise oil fat emulsion oral solution, drink and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101816422A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108208838A (en) * | 2018-03-09 | 2018-06-29 | 北京素维生物科技有限公司 | A kind of taste masking composition and application thereof |
| CN111840409A (en) * | 2020-07-08 | 2020-10-30 | 赣州哈克生物科技有限公司 | Preparation method and preparation equipment of tea oil fat emulsion |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1483398A (en) * | 2002-09-20 | 2004-03-24 | 西安力邦医药科技有限责任公司 | Vegetable oil fatty milk oral or injection preparation |
-
2010
- 2010-04-22 CN CN201010158455A patent/CN101816422A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1483398A (en) * | 2002-09-20 | 2004-03-24 | 西安力邦医药科技有限责任公司 | Vegetable oil fatty milk oral or injection preparation |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108208838A (en) * | 2018-03-09 | 2018-06-29 | 北京素维生物科技有限公司 | A kind of taste masking composition and application thereof |
| CN111840409A (en) * | 2020-07-08 | 2020-10-30 | 赣州哈克生物科技有限公司 | Preparation method and preparation equipment of tea oil fat emulsion |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105011310B (en) | A kind of production method of fish oil phosphatide cream beverage concentrate | |
| CN105104584B (en) | The preparation method of peony seed oil powdered oil containing active peptide | |
| CN101843336A (en) | Linseed oil fat emulsion oral solution, beverage and manufacturing method thereof | |
| CN1913911A (en) | Physiologically functional drinks and compositions | |
| CN101816444A (en) | Walnut oil fat emulsion oral solution or beverage and preparation method | |
| CN105476959B (en) | A kind of medium chain triglycerides nano-emulsion and preparation method thereof | |
| CN102429307A (en) | Low-calorie and total-nutrient beverage and preparation method thereof | |
| CN107136511A (en) | A kind of peony seed oil composition for promoting cranial nerve development, Peony-seed-oil soft capsule and preparation method thereof | |
| CN103039605A (en) | Pregnant woman milk powder capable of restraining early pregnancy reaction and preparation method thereof | |
| CN102948483A (en) | Blood fat reducing milk powder and preparation method thereof | |
| CN107660620A (en) | A kind of sheep base oil grease microcapsule powder and preparation method thereof | |
| CN101816423A (en) | Purple perilla seed oil lipid emulsion oral solution, beverage and manufacturing method thereof | |
| CN104664370A (en) | Chewable flax tablet | |
| CN102511864B (en) | Jujube high-consistency stock | |
| CN107441217B (en) | Oral emulsion rich in alpha-linolenic acid and preparation method thereof | |
| AU2020102282A4 (en) | Immunity-boosting gel candy for children and the method of preparation | |
| CN101167793A (en) | Walnut oil fat emulsion and manufacturing method thereof | |
| CN101869297A (en) | Compound evening primrose and perilla herb oil fat emulsion oral solution, beverage and preparation method | |
| CN101816422A (en) | Oenothera biennise oil fat emulsion oral solution, drink and preparation method thereof | |
| CN101869298A (en) | Compound walnut and linseed oil fat emulsion oral solution, beverage and preparation method | |
| CN102511858A (en) | Thickened red jujube pulp suitable for being taken by pregnant women and manufacturing technology of same | |
| CN101797270B (en) | Silkworm pupal oil fat emulsion intravenous fluid and preparation method | |
| JP5033275B2 (en) | Serum lipid lowering agent using coromantium | |
| CN101978949A (en) | Gamma-linolenate fat emulsion intravenous injection and preparation method thereof | |
| CN103053906B (en) | Preparation method of kiwi fruit seed oil oral emulsion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100901 |